Using large selections the unified system of landscape districting of HFRS natural foci with allocation of special geo-botanical provinces has been developed. This permits to avoid various deviations were found to appear during association of epizootiological and epidemiological indexes of separate towns and rural districts when estimating regional parameters. Adequacy of the offered system in confirmed by five-fold increase of the correlation between HFRS epizootiological parameters and antibody prevalence rate in humans. The steady maximum of all parameters was registered in the province situated in broad-leafed oak-line forests. Minimal values are found to correspond to one located in forest-steppe (with birch and asp forests) which poor fodder potential for rodents is well known. Other provinces between these ones are characterized by consecutive decrease of all index values according to the landscape type. According to estimated natural activity rate all the provinces are divided to three groups. The first one (antibody prevalence rate is above 5%) unites the high activity HFRS natural foci. Their common geographical location is on the territories with highest rodent population rates. The second group (antibody prevalence rate--2-4%) includes HFRS foci with average activity, and the third one (antibody prevalence rate is below 2%)--with low activity. The most of the last group provinces are situated on periphery or behind the bank vole living area.
Download full-text PDF |
Source |
---|
Nat Med
January 2025
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital & Institute, Beijing, China.
Programmed cell death protein-1 (PD-1) inhibitors plus chemotherapy have been the standard of care in the first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma; however, the survival benefits are modest in patients with low programmed death ligand 1 (PD-L1) expression. Here we investigated the efficacy and safety of cadonilimab (PD-1/cytotoxic T lymphocyte antigen-4 (CTLA-4) bispecific antibody) plus chemotherapy as first-line treatment in G/GEJ adenocarcinoma. The prespecified interim analysis is reported here.
View Article and Find Full Text PDFArch Sex Behav
January 2025
Hospital Moinhos de Vento, Rua Ramiro Barcelos 910, CEP, Porto Alegre, 90035-004, Brazil.
This study evaluated the association between HIV risk perception and sociodemographic and behavioral characteristics among cisgender female sex workers in the five regions of Brazil. A cross-sectional, multicenter study using respondent-driven sampling was used. Sex workers over 18 years of age and who reported commercial sex in the past four months were included.
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
January 2025
Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, 1397-1 Yamane, Hidaka-City, Saitama, 350-1298, Japan.
Purpose: Nivolumab plus ipilimumab (Nivo-Ipi) combination therapy is an effective first-line treatment for advanced non-small cell lung cancer (NSCLC). However, its effectiveness and feasibility in elderly patients (aged ≥ 75 years) remain unclear. This study aimed to investigate the efficacy and safety of first-line Nivo-Ipi therapy in elderly patients with NSCLC.
View Article and Find Full Text PDFRMD Open
January 2025
Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Objective: To assess patient's self-reported global assessment of health (PGA) in relation to inflammation, pain and disability in patients with rheumatoid arthritis (RA).
Methods: Data were obtained from the Better Anti-Rheumatic PharmacOTherapy early RA cohort, in which patients were scheduled for follow-up of 15 years. Longitudinal PGA trajectories were identified using hierarchical agglomerative clustering procedure with Wards methods, based on PGA assessments during the first 2 years.
Endocr J
January 2025
Department of Surgery, Ito Hospital, Tokyo 150-8308, Japan.
We investigated the association between a 500 MBq dose of radioactive iodine treatment (RAIT) and both thyroid nodule volume and thyroid function in patients with a single autonomous functioning thyroid nodule (AFTN). We retrospectively studied 201 patients with an AFTN who received RAIT at a dose of 500 MBq and were followed up for more than 2 years. Thyroid function at diagnosis, thyroid antibody positivity, treatment with antithyroid drugs before RAIT, cystic components of the nodule, and I uptake outside the nodule were assessed.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!